Healwell AI (AIDX) Stock Overview
Operates as a healthcare technology company in Canada, Australia, and New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
AIDX Community Fair Values
Create NarrativeSee what 27 others think this stock is worth. Follow their fair value or set your own to get alerts.
Healwell AI Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.83 |
| 52 Week High | CA$1.66 |
| 52 Week Low | CA$0.58 |
| Beta | -1.02 |
| 1 Month Change | -6.74% |
| 3 Month Change | -10.75% |
| 1 Year Change | -38.52% |
| 3 Year Change | 232.00% |
| 5 Year Change | -77.01% |
| Change since IPO | -81.64% |
Recent News & Updates
Recent updates
Why We're Not Concerned Yet About Healwell AI Inc.'s (TSE:AIDX) 26% Share Price Plunge
Feb 11
Why We're Not Concerned Yet About Healwell AI Inc.'s (TSE:AIDX) 30% Share Price Plunge
Nov 21Analysts Are Updating Their Healwell AI Inc. (TSE:AIDX) Estimates After Its Third-Quarter Results
Nov 09Healwell AI Inc. (TSE:AIDX) Analysts Are Reducing Their Forecasts For This Year
Nov 06A Look At The Intrinsic Value Of Healwell AI Inc. (TSE:AIDX)
Aug 14
Acquisition Will Create A Unified Global Healthcare Platform
The acquisition of Orion Health is expected to boost Healwell AI's international presence and revenue growth through enhanced data infrastructure and operational synergies.Healwell AI Inc.'s (TSE:AIDX) Stock Retreats 25% But Revenues Haven't Escaped The Attention Of Investors
Apr 19Healwell AI Inc. (TSE:AIDX) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless
Jan 14Investors Appear Satisfied With Healwell AI Inc.'s (TSE:AIDX) Prospects As Shares Rocket 34%
Nov 25Is Healwell AI (TSE:AIDX) A Risky Investment?
Nov 03Why Investors Shouldn't Be Surprised By Healwell AI Inc.'s (TSE:AIDX) P/S
Sep 10Healwell AI Inc.'s (TSE:AIDX) Intrinsic Value Is Potentially 46% Above Its Share Price
Jun 14Healwell AI Inc. (TSE:AIDX) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Mar 11Shareholder Returns
| AIDX | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 2.5% | 1.5% | 1.3% |
| 1Y | -38.5% | 40.7% | 44.6% |
Return vs Industry: AIDX underperformed the Canadian Healthcare industry which returned 35.7% over the past year.
Return vs Market: AIDX underperformed the Canadian Market which returned 41.1% over the past year.
Price Volatility
| AIDX volatility | |
|---|---|
| AIDX Average Weekly Movement | 11.0% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 11.0% |
| 10% most volatile stocks in CA Market | 19.2% |
| 10% least volatile stocks in CA Market | 3.9% |
Stable Share Price: AIDX has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: AIDX's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 570 | James Lee | www.healwell.ai |
Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases.
Healwell AI Inc. Fundamentals Summary
| AIDX fundamental statistics | |
|---|---|
| Market cap | CA$242.36m |
| Earnings (TTM) | -CA$38.56m |
| Revenue (TTM) | CA$103.80m |
Is AIDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AIDX income statement (TTM) | |
|---|---|
| Revenue | CA$103.80m |
| Cost of Revenue | CA$46.51m |
| Gross Profit | CA$57.29m |
| Other Expenses | CA$95.86m |
| Earnings | -CA$38.56m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 55.19% |
| Net Profit Margin | -37.15% |
| Debt/Equity Ratio | 64.9% |
How did AIDX perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/09 10:22 |
| End of Day Share Price | 2026/04/09 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Healwell AI Inc. is covered by 13 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Brian Kinstlinger | Alliance Global Partners |
| Gabriel Leung | Beacon Securities Limited |
| Douglas Taylor | Canaccord Genuity |